Related Experiment Videos
Carbohydrate biguanides as potential hypoglycemic agents
A B Reitz1, R W Tuman, C S Marchione
1Department of Chemical Research, McNeil Pharmaceutical, Spring House, Pennsylvania 19477-0776.
Journal of Medicinal Chemistry
|September 1, 1989
Summary
New biguanide-functionalized monosaccharides show potent hypoglycemic activity. Two compounds demonstrated efficacy comparable to established diabetes drugs phenformin and metformin.
Area of Science:
- Carbohydrate Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Biguanides are a class of compounds known for their hypoglycemic effects.
- Monosaccharide derivatives offer a scaffold for developing novel drug candidates.
- Exploring new chemical entities for diabetes management is crucial.
Purpose of the Study:
- To synthesize and evaluate novel monosaccharide-biguanide conjugates for hypoglycemic activity.
- To compare the efficacy of these novel compounds against existing hypoglycemic agents.
Main Methods:
- Synthesis of various monosaccharide derivatives functionalized with biguanide groups.
- Evaluation of hypoglycemic activity using a modified rat glucose-tolerance test.
- Quantitative assessment of blood glucose level inhibition.
Main Results:
- Compounds 8 and 23 exhibited significant hypoglycemic activity, comparable to phenformin and metformin.
- Compound 31 showed moderate activity, with 26% inhibition of blood glucose rise.
- Compounds 8 and 23 demonstrated potent inhibition of post-prandial hyperglycemia.
Conclusions:
- Monosaccharide-biguanide conjugates represent a promising class of compounds for managing hyperglycemia.
- Specific structural modifications on monosaccharides can yield potent hypoglycemic agents.
- Further investigation into these novel biguanide derivatives is warranted for potential therapeutic applications.